Accumulated evidence in the last decade implies that regulation of metabolism by p53 represents a reviving mechanism vital to prevent tumorigenesis. To gain a more in-depth understanding of metabolic regulation by baseline levels of p53, we employed both metabolomics and transcriptomics analysis with human colon cancer cell-line HCT116 depleted of p53. Metabolomics analyses with UPLC/quadrupole time-of-flight mass spectrometry identified 283 significantly changed metabolites including 138 important metabolites. Transcriptomics analysis with microarray revealed 1317 differentially expressed genes. By integrated analysis of both omics data, we found nucleotides metabolism and sulfur-related metabolism are of great importance. Our study provided a pilot comprehensive view of the metabolism regulated by p53 and suggests several potential p53 targets in metabolism for further study.
Accumulated evidence in the last decade implies that regulation of metabolism by p53 represents a reviving mechanism vital to prevent tumorigenesis. To gain a more in-depth understanding of metabolic regulation by baseline levels of p53, we employed both metabolomics and transcriptomics analysis with human colon cancer cell-line HCT116 depleted of p53. Metabolomics analyses with UPLC/quadrupole time-of-flight mass spectrometry identified 283 significantly changed metabolites including 138 important metabolites. Transcriptomics analysis with microarray revealed 1317 differentially expressed genes. By integrated analysis of both omics data, we found nucleotides metabolism and sulfur-related metabolism are of great importance. Our study provided a pilot comprehensive view of the metabolism regulated by p53 and suggests several potential p53 targets in metabolism for further study.
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position as one of the most studied proteins in cancer research. Known as 'guardian of the genome', p53 protein suppresses cancer progress through its regulation of a variety of cellular processes including cell cycle, apoptosis, senescence and autophagy. In recent years, accumulated evidence has implied that p53 plays vital roles in the regulation of cancer metabolism. p53 promotes mitochondrial metabolism through SCO2, p53R2, GLS2, TFAM, Mieap, Parkin, AIF, ME1 and ME2, represses glycolysis through TIGAR, Parkin, AKT/ mTOR, GLUT1/4, PGM, PDK2 and MCT1, and negatively regulates the pentose phosphate pathway (PPP) through its physical interaction with G6PD [10] [11] [12] [13] . p53 also enhances fatty acids degradation through upregulation of AMPK and CPT1, and inhibits lipid biosynthesis through decreasing SREBPs activities and limiting NADPH production [14] [15] [16] . Regulation of metabolism by p53 has provided new insights into transformation, tumor progression and chemoresistance, as well as potential therapeutic targets and regimes.
To gain a systematic profiling of the cellular metabolism regulated by p53, in this study, we carried out both metabolomics and transcriptomics analysis of the p53-depleted human colon cancer cell-line HCT116 p53À/À. Our results not only confirmed previous reported metabolism pathways affected by p53 but also indicated that nucleotides metabolism and sulfurrelated metabolism could also be controlled by p53.
Materials and methods

Cell culture, chemical and reagents
The p53+/+ and p53À/À HCT116 human colon cancer cell lines were provided by Bert Vogelstein, Johns Hopkins University, cultured in McCoy's 5A medium supplemented with 10% FBS and 100 lgÁmL À1 penicillin and 100 lgÁmL À1 streptomycin (Life Technologies, Carlsbad, CA, USA). Chemical standards were all purchased from Sigma Aldrich (St. Louis, MO, USA) and J&K Scientific (Beijing, China). Ammonium acetate and ammonium hydroxide were purchased from Fisher Scientific (Morris Plains, NJ, USA). LC-mass spectrometry (MS) grade water (H2O), methanol (MeOH) and acetonitrile (ACN) were purchased from Honeywell (Muskegon, MI, USA).
Cell metabolites extraction
Cell pellets were snap-frozen in liquid nitrogen and stored at À80°C until use. Metabolites were extracted from 100 mg cell pellets by adding 200 lL H 2 O and 800 lL methanol : CAN (1 : 1) mix solution, following 4 min grinding with steel ball and 5 9 3 min ultrasonic extraction. After incubation at À20°C for 1 h, samples were centrifuged and 800 lL of supernatant was evaporated to dryness at room temperature and reconstituted in 100 lL acetonitrile/H20 (1 : 1). The solutions were centrifuged and 70 lL supernatant was taken as final samples for the ultra-HPLC-quadrupole time-of-flight MS (UPLC/Q-TOF MS) analysis.
Metabolomics analysis
Cell extracts were analyzed with 1290 series HPLC system (Agilent Technologies, Santa Clara, CA, USA) coupled with triple TOF 6600 (AB Sciex, Chromos, Singapore), equipped with an electrospray ionization (ESI) in either positive or negative mode. Two microliters of samples was injected and separated by coupling an ACQUITY UPLC BEH amide column (1.7 lm, 2.1 9 100 mm; Waters, Milford, CT, USA) with a BEH C 18 column (2.1 9 50 mm, 1.7 m; Waters) at 35°C by reversed-phase liquid chromatography. The mobile phase consisting of 25 mM NH 4 OAc and 25 mM NH 4 OH (pH = 9.75) was set at 0.3 mLÁmin
À1
. The triple TOF mass spectrometer and the acquisition software Analyst TF 1.7 (AB Sciex) were used to acquire MS/MS spectra on an information-dependent basis. ESI source conditions were set as follows: ion source gas 1 at 60, ion source gas 2 at 60, curtain gas at 30, source temperature at 550°C, ion spray voltage floating (ISVF) at 5500 V and 4500 V in positive and negative modes respectively. The self-build MS/MS database and Fiehn metabolomics library [17] were used to screen and match the identified pairs of retention time (RT)-m/z.
Microarray analysis
HCT116 p53+/+ and p53À/À cells were washed three times with PBS and harvested with a scraper (n = 3 for each group). Total RNA was isolated with RNeasy Mini Kit (Qiagen, Germantown, MD, USA) and the quantity and quality assessed with Nanodrop spectrophotometer (Thermo Fisher Scientific, Rockford, IL, USA) by 260/ 280 and 260/230 absorption ratios. Double-stranded cDNA and labeled complementary RNA (cRNA) were synthesized by the Affymetrix IVT kit (Affymetrix, Santa Clara, CA, USA). Twenty micrograms fragmented cRNA was then hybridized to the Affymetrix human U133A Plus 2.0 chips containing~22 000 probe sets mapping tõ 14 500 well-characterized human genes (Affymetrix). The chips were further processed according to the manufacturer's protocol. The arrays were scanned with a laser scanner and the data were collected and processed using the Affymetrix GCOS software (version 11.0; Affymetrix). All probe Set ID was submitted to the DAVID Bioinformatics Resources (Version 6.8; National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, USA) and convert into gene ID for further analysis [18] .
Western blot
Whole-cell protein lysates were prepared by lysis in RIPA buffer, diluted in SDS/PAGE protein sample buffer and heated for 5 min at 95°C prior to fractionation on SDS/ PAGE and transferred to Immobilon P (Millipore, Billerica, MA, USA) membranes. The membranes were incubated with p53 antibody (DO-1; Santa Cruz Biotechnology, Dallas, TX, USA) overnight at 4°C, washed with TBST and incubated with horseradish peroxidase-conjugated secondary antibodies at room temperature. Protein was visualized with SuperSignal West Pico Chemiluminescent Substrate (Thermo Fisher Scientific).
Quantitative real-time PCR
Cellular mRNA was isolated by Dynabeads mRNA direct kit (Life Technologies) and reverse transcribed by SuperScript III (Life Technologies) following manufacturer's instructions. Quantitative real-time PCR was performed on the ViiA TM 7 Real-Time PCR System (Applied Biosystems, Carlsbad, CA, USA) in triplicates using SYBR Green (Life Technologies). Cellular mRNA levels of interested genes were normalized to the eukaryotic translation initiation factor 3S5 (EIF3S5 or TIF). Statistical analysis was performed using Microsoft Excel and the statistical significance was determined by two-tailed Student's test.
Bioinformatics analysis
Heatmaps were created using R-Project software (Vanderbilt University, Nashville, TN, USA). The multivariate statistical analysis was performed by SIMCA 14.1 software (Umetrics, Ume a, Sweden) and employing both principal components analysis (PCA) and orthogonal projection to latent structurediscriminant analysis (OPLS-DA) module. PCA is an unsupervised, reductive statistical modeling technique, while OPLS-DA is a reduced-dimension model that improves the partial least squares (PLS) method by combining orthogonal signal correction (OSC). It filters out noise information between two matrices (X and Y) [19] . The quality of OPLS-DA models was evaluated by the predictive ability parameter Q 2 and the goodness-of-fit parameter R
2
. Both values higher than 0.5 indicate good quality of OPLS-DA models. The first principal component of variable importance in the projection (VIP) values was calculated to find the important different metabolites. The sum of squares of all VIPs is equal to the number of terms in the model. Hence, the average VIP is equal to 1.0. VIP values larger than 1.0 indicates 'important' metabolites, and values below 1.0 indicate 'unimportant' metabolites. Metabolic pathway analysis and the integrated pathway analysis were carried out using MetaboAnalyst [20] (http://www.metaboanalyst.ca), under the 'Pathway Analysis' module and 'Integrated Pathway Analysis' module, respectively, and searching against human pathway library from Kyoto Encyclopedia of Genes and Genomes (KEGG) database. In the analysis, over-representation analysis (ORA) was implemented based on hypergeometric test to evaluate whether a particular metabolite set was represented more than expected by chance within the given list. The pathway topology analysis measuring node importance was done with degree centrality, which is defined as the number of links occurred upon a node. In MetaboAnalyst, only out-degree is considered for node importance measure, which assumed that nodes in upstream will have regulatory roles for the downstream nodes, not vice versa. Differentially expressed genes (DEGs) from microarray data were identified using a standard paired t-test and multiple testing correction with Benjamini-Hochberg procedure to provide a critical value adjusted to 5% false discovery rate (FDR) [21] . Gene ontology (GO) enrichment analysis was done by PANTHER GOSlim annotations on the GO Consortium (http://www.gene ontology.org) [22] . Breast cancer patient gene expression data were retrieved from cBioPortal (http://www.geneontol ogy.org) of the Cancer Genome Atlas (TCGA) project and analyzed with Prisma software with student's t-test.
Results
Loss of p53 significantly changes intracellular metabolites
To explore the p53-dependent cellular metabolites changes, the metabolic profile of the HCT116 p53À/À cells compared with the parental p53+/+ cells was characterized by UPLC/Q-TOF MS in both positive and negative ion modes. First of all, the cell line was validated by western blot to show loss of p53 proteins (Fig. S1 ). The method was verified with quality control (QC) sample prepared by mixing both cell lines. QC sample was analyzed four times to evaluate the stability of the testing system. Figure S2 shows the typical UPLC/Q-TOF MS total ion chromatogram (TIC) of the QC sample in both negative and positive ESI modes. The relative standard deviation of ion intensity was < 30%, and the feature ratio of the negative ion and the positive ion was 84.07% and 86.70% respectively. The QC results proved that the UPLC/Q-TOF MS method had excellent stability and reproducibility. After preprocessing, the UPLC/Q-TOF MS data matrix was generated comprising of the RT, the normalized peak area and the m/z value. A total of 7424 pairs of RT-m/z were found, of which 3514 in negative ion mode and 3910 in positive ion mode. The list was further aligned against the Fiehn metabolomics library [17] and the self-built database containing more than 800 standards. A total of 283 metabolites, including 126 increased and 157 decreased, were identified as the metabolic signature of HCT116 p53À/À cells compared with p53+/+ cells ( Fig. 1 and Table S1 ).
We next thought to confirm that depletion of p53 indeed changes the overall intracellular metabolites constitution by multivariate statistical analysis. PCA analysis with the 7424 pairs of RT-m/z revealed an obvious separation between p53À/À group and p53+/+ group in positive ion mode ( Fig. 2A) , negative ion mode (Fig. 2B ) or a combination of both modes (Fig. 2C) . To further verify the results of PCA analysis, we performed OPLS-DA analysis with the 283 validated metabolites. Comparing with PCA, which is usually used to test whether a set of observations can be grouped into different classification and to find out outliers, OPLS-DA focuses on grouping and more efficient extraction of intergroup variance information [23] . The OPLS-DA coefficient analysis clearly separated the p53À/À cells with the p53+/+ cells per their metabolic profiles (Fig. 2D) . So, as expected, our results clearly indicate that p53 plays important roles in metabolism and loss of p53 could cause significant alterations of intracellular metabolites.
To find out the most important metabolites tightly related to loss of p53 protein, variable importance in projection (VIP) analysis was carried out with 283 validated metabolites (Table S1 ). VIP value represents the importance of each variable/metabolite contributing to the separation of the tested groups. Variable with VIP value > 1.0 was specified as important metabolites (Fig. 3) . Using this cutoff VIP value, 138 metabolites were identified as potential biomarkers correlated with loss of p53 protein (Table S2 ). The list of the selected important metabolites was then analyzed by the metabolite set enrichment analysis (MESA) module in METABOANALYST 3.0 [20] . As shown in Fig. 4 most of the important metabolites were involved in nucleotides metabolism (purine metabolism and pyrimidine metabolism), amino acids metabolism (alanine, aspartate and glutamate metabolism, cysteine and methionine metabolism, lysine biosynthesis, lysine degradation, phenylalanine, tyrosine and tryptophan biosynthesis, beta-alanine metabolism and glutathione metabolism), carbohydrate metabolism (citrate cycle and pyruvate metabolism), metabolism of cofactors and vitamins (vitamin B6 metabolism and one carbon pool by folate) and lipid metabolism (synthesis and degradation of ketone bodies, glycerophospholipid metabolism and ether lipid metabolism). The diversity of the metabolites confirmed the wide effect of p53 on intracellular metabolism regulation.
Loss of p53 significantly changes gene expression
As a transcription factor, the transcriptional targets of p53 were extensively studied by all kinds of transcriptomic methods. However, most of these studies were focused on stimulated p53 by chemotherapy, radiation or overexpression [24] . In few studies employed cell lines deficient in p53, however, the cell lines were served as negative control for limited p53 response, not compared with the wild-type (WT) counterpart cell lines to explore the functions of baseline levels of p53 [25, 26] . So, we performed genome-wide mRNA microarray profiling of the p53À/À cells compared to the p53+/+ cells. A total of 1317 DEGs were identified, including 536 upregulated genes and 781 downregulated genes (Fig. S3 ). Our data indicate that, even at a baseline level, p53 can regulate numerous genes, highlighting the important biological roles when cells lose the expression of p53 protein. It should be noted that, the genes identified here could be regulated by p53 either directly or indirectly, as loss of p53 may alter expression of other transcriptional factors.
Next, we performed GO analysis of the 1317 DEGs utilizing the online bioinformatics tool PANTHER [22] , in which DEGs were classified into three categories of cellular component, biological process and molecular function. All DEGs were almost equally distributed into discrete cellular compartments, like cytosol, nucleus, membranes and organelles, indicating the diverse functions of p53-regulated genes (Fig. S4A) . Indeed, loss of p53 affected all kinds of molecular functions including cadherin binding, cell adhesion molecular binding, kinase binding, macromolecular complex binding, enzyme regulator activity, identical protein binding, RNA binding, catalytic activity, protein binding and ion binding (Fig. S4B) . The biological processes affected by baseline levels of p53, such as stress response (cellular response to UV, regulation of cellular response to stress), cell cycle progression (cell cycle phase transition, negative regulation of cell cycle process, mitotic cell cycle phase transition), and apoptosis regulation (signal transduction by p53 class mediator; Fig. 5 ) are in great consistent with those published global analysis of p53 affected pathways in cancer cells [26] [27] [28] [29] [30] . However, unlike stress-induced p53 which differentially affected pathways depends on exposure type [25, 31] , baseline levels of p53 lack this predisposition with equal distribution of enriched biological processes (Fig. 5) . It is noted that sulfur compound metabolic process was enriched, which has not been reported by previous studies [26] [27] [28] [29] [30] . To further confirm the results of GO analysis, we did the analysis in a more stringent setting with FDR at 1%, which included 481 DEGs. Similar biological processes, including apoptosis/cell death, cell cycle/growth, proteolysis and sulfur compound metabolic process, were enriched (Fig. S5) . Taken together, the GO analysis is consistent with the miscellaneous functions of p53 and highlights the importance of baseline levels of this protein.
Basal p53 regulates metabolic pathways as revealed by integrated omics analysis
Analysis integrated of multi-omics provides a more comprehensive picture of the organism studied and greatly increases the validity of the results [32, 33] . So, we combined both metabolomics and transcriptomics results and carried out the integrated pathway analysis by MetaboAnalyst 3.0. As shown in Fig. 6 , 20 pathways were enriched. Among these pathways, citrate cycle, pyruvate metabolism and amino acids metabolism could be grouped into carbohydrate metabolism, which has been extensively reviewed [12, 13, 34, 35] . Synthesis and degradation of ketone bodies, glycerophospholipid metabolism and ether lipid metabolism could be grouped into lipid metabolism, which has been also widely studied [14, 36] . Knockout of p53 also affected glutathione metabolism, indicating its role in cellular redox hemostasis [37] . Besides theses known metabolic pathways affected by p53, we also identified purine metabolism, pyrimidine metabolism, sulfur metabolism, and cysteine and methionine metabolism. These pathways were less studied with respect to p53, which will be discussed below.
It should be pointed out that all the pathways regulated by baseline levels of p53 are not isolated. On the contrary, these pathways are closely coupled and interactive. There are several key metabolites serve as nodes linking the pathways into an integrated network. Acetyl-CoA, the catabolic product of glucose and fatty acid, is the hub of glycolysis/gluconeogenesis, pyruvate metabolism, citrate cycle (TCA cycle), synthesis and degradation of ketone bodies, glutathione metabolism, glycerophospholipid and ether lipid metabolism, as well as amino acid metabolism. 5-Phosphoribosyl 1-pyrophosphate (PRPP) is the central linker of the PPP, nucleotides metabolism and histidine metabolism. Glutamate interacts with arginine and proline metabolism, histidine metabolism and glutathione metabolism. Pyruvate is the node of glycolysis/gluconeogenesis, citrate cycle (TCA cycle) and amino acid metabolism. Serine is not merely the precursor to glycine, cysteine and sphingolipids, but also the product 3-phosphoglycerate (an intermediate from glycolysis) oxidation.
Basal p53 regulates nucleotides metabolism
Integrated pathway analysis identified 'purine metabolism' and 'pyrimidine metabolism' as the most significant pathways, indicating an essential role for p53 in nucleotides metabolism, as demonstrated by the heatmap visualization of significantly changed intracellular metabolites and DEGs (Fig. 7A) . Depletion of p53 decreased the expression of most of the genes in the gene expression signature. The mRNA levels of all 14 DEGs were confirmed by quantitative real-time PCR analysis under both basal and stimulated conditions by comparing p53+/+ cells with p53À/À cells or fluorouracil (5-FU) treatment respectively (Fig. 7B) . Among these genes, RRM2B is a well-known p53 target, supplying deoxyribonucleotides for DNA repair and thus promoting cell survival in response to DNA damage [38] . Nucleoside diphosphate kinase (NDK), a hexamer composed of A and B isoforms encoded by NME1 and NME2, respectively, catalyzes the synthesis of nucleoside triphosphates other than ATP. NDK is known as a tumor metastasis suppressor and has been recorded to be regulated by p53 [39] . NT5E encodes protein CD73, which belongs to 5'-nucleotidase family and hydrolyzes extracellular nucleotides into membrane permeable nucleosides. Consistent with being a putative p53 target identified in our study, decreased activity of CD73 was reported in B-cell chronic lymphocytic leukemia [40] . PDE3B and PDE8A belong to the cyclic nucleotide phosphodiesterase (PDE) family, which are critical regulators of second messenger cAMP and/or cGMP by controlling their degradation. The mRNA expression of PDE3B was reported to be correlated with p53 following metformin treatment [41] . Thymidine kinase 1 (TK1) is the cytosolic form of thymidine kinase, which catalyzes the addition of a gamma-phosphate group to thymidine and is required for DNA replication. TK1 accumulates in p53-null cells during recovery from DNA damage [42] . Other genes have not been reported to be regulated by p53 but they do play important roles in nucleotide metabolism, like POLR1B in transcription of rRNA, ENPP4 in hemostasis of adenosine and PRIM1 in the synthesis of small RNA primers for the Okazaki fragments during discontinuous DNA replication (Fig. 7C) .
Basal p53 regulates sulfur-related metabolism
It is noted that sulfur metabolism and cysteine and methionine metabolism, the sulfur-containing amino acids, possessed important positions in the integrated pathway analysis overview (Fig. 6) . Sulfur metabolism involves the absorption and decomposition of nonmetallic element sulfur or sulfur-containing biomolecules, which is important for the interaction between human genetics and epigenetics and the maintenance of cellular redox homeostasis [43] . Loss of p53 changed the mRNA levels of several sulfur metabolism genes by microarray analysis (Fig. 8A ), which were further confirmed by quantitative real-time PCR analysis under both depletion of p53-and 5-FU-stimulated conditions (Fig. 8B) . PAPSS2 encodes the bifunctional enzyme 3 0 -phosphoadenosine 5 0 -phosphosulfate synthetase 2 (PAPSS2), which catalyzes the synthesis of 3 0 -phosphoadenosine 5 0 -phosphosulfate (PAPS) from ATP and inorganic sulfate, providing the activated sulfur source in mammals. Ethylmalonic encephalopathy 1 protein (ETHE1) catalyzes the oxidation of the persulfide, giving rise to sulfite. It was suppressed with depletion of p53 as well. So, it was reasoned that sulfur metabolism is hampered in HCT116 p53À/À cells, which was confirmed with the decreased level of downstream metabolite taurine. On the other hand, L-methionine level was significantly higher in p53 depleted cells (Fig. 8A) . This was in line with the increased expression of methylthioadenosine phosphorylase (MTAP), a key enzyme in the salvage pathway of methionine (Fig. 8C) . Furthermore, MTAP mRNA expression level, retrieved from the TCGA study [44] , is also significantly higher in p53 mutant (MT) patients than p53 WT patients with invasive breast carcinoma (Fig. 8D) . The decreased intracellular level of Sadenosylmethionine (SAM) and the increased level of S-adenosyl-L-homocysteine (SAH) could result from the elevated expression of DNMT1, which encodes DNA methyltransferase and converts SAM into SAH (Fig. 8C) . So, p53 exhibited a complex control of sulfur metabolism and cysteine and methionine metabolism.
Discussions
As one of the most studied tumor suppressor, p53 has been widely accepted to function through regulation of cell death, senescence and cell cycle arrest in response to stress [13] . However, the concept has been challenged recently. The p21 knockout mice [45] , the puma knockout mice [46] , and the p21, puma and noxa triple knockout mice [47] are all not tumor prone as the p53 knockout mice, suggesting that p53-mediated cell cycle arrest, apoptosis and senescence are not necessary for its tumor-suppressive function. While in a p53 MT mouse model, even p53-mediated cell cycle arrest, apoptosis and senescence functions are impaired, the retained metabolism regulation function of p53 is still able to suppress tumor growth [48] . These evidences indicate that regulation of metabolism might be more critical for the tumor-suppressive function of p53 than other canonical pathways. Regulation of metabolism by p53 is a rapidly growing field in cancer research and has been extensively reviewed [15, 49, 50] . However, no studies employing omics technologies to provide a global profile with respect to baseline levels of p53 have been reported. Here, we gave a pilot study by integrating metabolomics and transcriptomics analysis of human colon cancer cell-line HCT116 p53À/À comparing with the WT counterpart. Most of the p53 studies, especially the transcriptomics studies, investigated the cellular response to stress, like chemotherapy and radiotherapy, where p53 is induced at high levels. In this study, by comparing p53À/À cells with p53+/+ cells, we were focused on the basal p53 in nonstressed condition. It should be noted that, under most circumstances, it is the basal rather than the induced level of p53 that regulates cellular metabolism [11, 51, 52] . As a tumor suppressor, loss of function is the physiological process of p53 resulting in tumorigenesis. The discrepancy in affected pathways between stresses-induced p53 and basal p53 in GO analysis emphasized the point (Fig. 5) . So, the model employed in this study, even though not the most appropriate one, is more confined to the physiological conditions and thus more meaningful to study the regulation of metabolism by p53 and tumorigenesis.
It is well established that nucleotide biosynthesis is critical for cell proliferation and nucleotide deficiency could trigger cell cycle arrest and cell death in a p53-dependent manner. However, whether p53 can regulate nucleotide biosynthesis is less explored and with controversial reports. On one hand, p53 has been reported to inhibit GMP synthetase (GMPS), a ratelimiting enzyme in de novo purine biosynthesis, leading to cellular senescence [53] . p53 is also able to inhibit IMP dehydrogenase (IMPDH), the enzyme catalyzes IMP to XMP and thus inhibits GTP production [54, 55] . p53 has been shown to inhibit the expression of uridine phosphorylase (UPase), the key enzyme in the pyrimidine salvage pathway and controls the homeostatic of uridine [56] . On the other hand, a recent study showed that p53 promotes nucleotide biosynthesis in response to DNA damage through repression of glycolysis [57] . Again, most of these studies were related to stress-induced or exogenously overexpressed p53, not the physiological baseline levels of p53. Another study by Kollareddy et al. [58] reported MT p53 gain-of-function to transcriptionally upregulate nucleotide biosynthesis genes, thereby supporting cancer cell proliferation and invasion. However, in this study, we were focusing on the function of WT p53 at baseline levels. We have demonstrated that loss of p53 is prone to inhibit nucleotide biosynthesis in general, as most of the genes were suppressed in the pathway (Fig. 7) .
Sulfur-containing molecules are reported to regulate p53 activity [59] . However, whether p53 can regulate endogenous sulfur-related metabolism remains elusive. In this study, we have provided a pilot picture on this issue. Among genes regulated by p53 in sulfur-related metabolism, only DNMT1 is known to be a p53 target [60] . All other genes, like PAPSS2, ETHE1 and MTAP, have not been reported to be regulated by p53 and more experiments are needed to validate the points. The baseline levels of p53 has been shown to exert antioxidant function and thus protect cells from ROS-induced DNA damage and tumorigenesis [61] . Here, we show that loss of p53 suppresses sulfur metabolism through downregulation of PAPSS2 and/or ETHE1. As sulfur is an important element in the synthesis of cysteine and related molecules like taurine and glutathione, which are important for intracellular redox hemostasis, our study provides new perspectives regarding the mechanism of antioxidant function of p53. We also found that depletion of p53 significantly increased intracellular level of methionine which is required for translation initiation and transmethylation. Comparing to normal cells, cancer cells are methionine dependent because of lacking the ability to recycle methionine from homocysteine remethylation [62] . Our finding indicates that p53 may suppress tumor growth by limiting the intracellular availability of methionine, and also highlights the potential of MTAP, a key enzyme in the salvage pathway of methionine, to be a therapeutic cancer target (Fig. 8) .
In summary, by integrating metabolomics and transcriptomics analysis of HCT116 p53À/À cells compared to the WT parental cells, we have provided a bird view of the intracellular metabolic regulation by tumor suppressor p53. Besides canonical metabolic pathways affected by p53, like the glycolysis pathway, the PPP, citrate cycle (TCA cycle), amino acids metabolism and lipids metabolism, we found nucleotides metabolism and sulfur-related metabolism are of great importance.
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